SCHEMBL10744445

SCHEMBL10744445

COc1cc2c(cc1S(C)(=O)=O)CCN(C(C)=O)CC2c1ccc(S(=O)(=O)Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CA1 P00915 7/20 0.40
▸ CA2 P00918 7/20 0.40
▸ CA9 Q16790 7/20 0.40
▸ CA14 Q9ULX7 7/20 0.40
▸ CA7 P43166 5/20 0.40
▸ CA12 O43570 4/20 0.40
▸ LMNA P02545 1/20 0.39
▸ TRPV1 Q8NER1 2/20 0.38
▸ ADAM17 P78536 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ GPR119 Q8TDV5 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10345941 0.94 CYP3A4 (0.42) CYP3A4CYP2D6CA1CA2CA9
SCHEMBL10748134 0.93 CYP3A4 (0.43) CYP3A4CYP2D6CA1CA2CA9
SCHEMBL10746813 0.88 CYP3A4 (0.54) CYP3A4CYP2D6CA1CA2CA9
SCHEMBL10345899 0.85 CYP2D6 (0.53) CYP3A4CYP2D6CA1CA2CA9
SCHEMBL10345840 0.82 CYP2D6 (0.53) CYP3A4CYP2D6CA1CA2CA9
SCHEMBL10345859 0.80 CYP2D6 (0.53) CYP3A4CYP2D6CA1CA2CA9
SCHEMBL10743718 0.77 CYP3A4 (0.53) CYP3A4CYP2D6CA1CA2CA9
SCHEMBL10749624 0.76 CYP3A4 (0.38) CYP3A4CYP2D6CA1CA2CA9
SCHEMBL10744663 0.75 ESR1 (0.49) CYP3A4CYP2D6LMNATRPV1MEN1
SCHEMBL10350544 0.74 CA7 (0.45) CA1CA2CA9CA14CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0244088-A2 1-Phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders SMITHKLINE BEECHAM CORPORATION (US) 1987-11-04 — — EP disclosed
Send feedback